Fumitaka Kudo

3.3k citations
110 papers · 2.6k indexed · h-index 31

Fumitaka Kudo

109 papers receiving 2.6k citations

Peers

Fumitaka Kudo
Comparison fields: 5 of 92
  • Pharmacology 1.4k
  • Biotechnology 410
  • Organic Chemistry 816
  • Molecular Biology 1.8k
  • Renewable Energy, Sustainability and the Environment 284
Replace Steven G. Van Lanen with:
Steven G. Van Lanen United States
Jiahai Zhou China
Akimasa Miyanaga Japan
Yi Yu China
Max J. Cryle Australia
Pekka Mäntsälä Finland
Gong‐Li Tang China
Andrew M. Piggott Australia
Kira J. Weissman Germany
Zixin Deng China
Fumitaka Kudo relative to Steven G. Van Lanen United States Steven G. Van Lanen's profile →
Citations per field
00.5×
Steven G. Van Lanen · 1×
Citations per year

Countries citing papers authored by Fumitaka Kudo

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Kudo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Kudo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Kudo more than expected).

Fields of papers citing papers by Fumitaka Kudo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Kudo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Kudo. The network helps show where Fumitaka Kudo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fumitaka Kudo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fumitaka Kudo Line = papers co-authored together Fumitaka Kudo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20243
3 20231
4 20233
5 20216
6 201721
7 201632
8 201649
9 201535
10 201512
11 201458
12 201410
13 20139
14 201335
15 201225
16 200917
17 200974
18 20099
19 200749
20 199818

About Fumitaka Kudo

Fumitaka Kudo is a scholar working on Pharmacology, Biotechnology and Molecular Biology, having authored 110 papers that have together received 2.6k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (70 papers), Carbohydrate Chemistry and Synthesis (24 papers), Genomics and Phylogenetic Studies (15 papers), Enzyme Structure and Function (15 papers), Biochemical and Molecular Research (13 papers), Plant biochemistry and biosynthesis (12 papers), Metalloenzymes and iron-sulfur proteins (12 papers) and Chemical Synthesis and Analysis (11 papers). The work is most often cited by research in Pharmacology (1.4k citations), Biotechnology (410 citations) and Organic Chemistry (816 citations). Fumitaka Kudo has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Tadashi Eguchi, Akimasa Miyanaga, Shizuko Kakinuma, Kenichi Yokoyama, Hideyuki Tamegai, Yuji Shinohara, Shusuke Sato, Daijiro Ohmori, David E. Cane and Chaitan Khosla. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026